A microarray study of gene and protein regulation in human and rat brain following middle cerebral artery occlusion

Table 2 Clinical Details of Patients

Patient no.	Age/sex	Survival after stroke	NIHSS on admission	Hypertension^a	Coronary artery disease	Atrial fibrillation	History of TIA/previous stroke	Hypercholesterolemia^b	Smoking	Obesity^c	Cause of death	Antiplatelets	Statins^d	RSA-b^e
1	63/F	2 days	26	Yes	No	No	No	No	No	No	Large ischemic stroke	No	No	Yes
2	84/M	3 days	21	Yes	Yes	No	No	No	Yes	No	Malignant stroke	No	No	No
3	68/M	3 days	24	Yes	Yes	No	No	Yes	No	No	Brain oedema	No	No	Yes
4	84/M	6 days	22	Yes	Yes	No	No	No	No	No	Cardiac failure	Yes	Yes	No
5	51/M	9 days	25	Yes	No	No	Yes	No	No	No	Respiratory infection	Yes	No	No
6	74/M	15 days	22	Yes	Yes	No	No	No	No	Yes	Heart attack	Yes	No	Yes
7	86/M	15 days	14	Yes	Yes	No	No	Yes	No	No	Urinary infection	Yes	No	No
8	58/M	17 days	16	Yes	Yes	No	No	Yes	Yes	No	Cardiac infarction	Yes	No	No
9	74/M	20 days	12	Yes	Yes	No	No	No	No	No	Bronchial aspiration	Yes	No	No
10	73/M	26 days	14	Yes	Yes	No	No	Yes	No	Yes	Respiratory infection	Yes	No	Yes
11	75/M	29 days	20	No	Yes	Yes	No	No	Yes	No	Septic shock	Yes	No	Yes
12	60/F	37 days	18	Yes	Yes	No	No	Yes	Yes	No	Pulmonary embolism	Yes	No	No

^a Blood pressure greater than 135/85 mmHg.
^b Serum total cholesterol levels greater than 5.2 mmol.
^c Body mass index greater than 30.
^d Patients who were on statins before the ischemic stroke.
^e Patients taking either angiotensin converting enzyme inhibitors or angiotensin type I receptor antagonists.
M = male; F = female; NIHSS = NIH Stroke Scale; TIA = Transient Ischaemic Attack.

ISSN: 1471-2202